Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PET imaging of gene expression.

Ronald Blasberg1

  • 1Departments of Neurology and Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. blasberg@neuro1.mskcc.org

European Journal of Cancer (Oxford, England : 1990)
|October 22, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A tumor metabolism-angiogenesis-immune axis governs immunotherapy responses.

bioRxiv : the preprint server for biology·2026
Same author

LDH-A-Modulation and the Variability of LDH Isoenzyme Profiles in Murine Gliomas: A Link with Metabolic and Growth Responses.

Cancers·2022
Same author

Genetic and Drug Inhibition of LDH-A: Effects on Murine Gliomas.

Cancers·2022
Same author

Introducing a new reporter gene, membrane-anchored <i>Cypridina</i> luciferase, for multiplex bioluminescence imaging.

Molecular therapy oncolytics·2021
Same author

CTLA-4 blockade drives loss of T<sub>reg</sub> stability in glycolysis-low tumours.

Nature·2021
Same author

Imaging CXCR4 Expression with Iodinated and Brominated Cyclam Derivatives.

Molecular imaging and biology·2020
Same journal

Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Real-world experience of larotrectinib in children, adolescents and young adults with TRK fusion solid tumors: The SACHA-France experience.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Corrigendum to "Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed" [Eur J Cancer 202, May 2024, 114006].

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Letter to the editor Re: Patient-reported outcomes from the LAURA study: Osimertinib in patients with unresectable stage III EGFR-mutated non-small cell lung cancer after definitive chemoradiotherapy.

European journal of cancer (Oxford, England : 1990)·2026
See all related articles

Noninvasive molecular imaging uses reporter genes and probes to visualize biological processes in vivo. This technology allows for tracking gene expression and cellular activity, with potential for clinical translation.

Area of Science:

  • Molecular imaging
  • Biomedical engineering
  • Gene expression analysis

Background:

  • Noninvasive in vivo molecular imaging has advanced significantly, utilizing nuclear (PET, gamma camera), MRI, and optical systems.
  • Current strategies often employ an "indirect" approach, linking reporter genes with complementary reporter probes.
  • Probe accumulation indirectly reflects reporter gene expression levels.

Purpose of the Study:

  • To review noninvasive in vivo molecular imaging strategies.
  • To discuss the application of reporter gene systems for monitoring biological processes.
  • To explore challenges in translating molecular imaging to clinical settings.

Main Methods:

  • Utilizing reporter gene constructs (constitutive or inducible) driven by promoter/enhancer elements.

Related Experiment Videos

  • Employing complementary reporter probes for signal detection.
  • Applying Positron Emission Tomography (PET) imaging for visualizing biological processes in animal models.

    • Main Results:

    • Demonstrated examples of imaging endogenous biological processes, including p53-dependent gene expression and T-cell receptor-dependent T-lymphocyte activation.
    • Reporter gene systems can monitor gene (vector) activity, control gene expression, or sense endogenous promoters and transcription factors.
    • Accumulation of radiolabeled probes in PET imaging provides insights into reporter gene expression.

    Conclusions:

    • Noninvasive molecular imaging with reporter gene systems offers powerful tools for studying biological processes in vivo.
    • The technology shows promise for applications such as monitoring gene therapy and understanding disease mechanisms.
    • Addressing challenges is crucial for the successful clinical translation of these advanced imaging techniques.